GnRH-agonist induced depressive and anxiety symptoms during in vitro fertilization-embryo transfer cycles
- PMID: 20801439
- DOI: 10.1016/j.fertnstert.2010.07.1073
GnRH-agonist induced depressive and anxiety symptoms during in vitro fertilization-embryo transfer cycles
Abstract
To determine whether the use of a GnRH agonist inducing a hypogonadic state during IVF-ET cycles induces negative mood symptoms, we conducted a prospective randomized study in 108 women comparing two different controlled ovarian stimulation protocols. A significant phase effect was observed for depression and anxiety symptoms during IVF-ET cycles reflecting an increase in symptoms between the hypogonadal phase and the peak in gonadotropin stimulation; however, the hypogonadal phase induced by the GnRH agonist was not associated with a significant increase in any of the studied mood parameters.
Trial registration: ClinicalTrials.gov NCT01032421.
Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical